161 related articles for article (PubMed ID: 10074101)
1. Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction.
Sunyach C; Rollier C; Robaczewska M; Borel C; Barraud L; Kay A; Trépo C; Will H; Cova L
J Virol; 1999 Apr; 73(4):2569-75. PubMed ID: 10074101
[TBL] [Abstract][Full Text] [Related]
2. In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization.
Sunyach C; Chassot S; Jamard C; Kay A; Trepo C; Cova L
Virology; 1997 Aug; 234(2):291-9. PubMed ID: 9268160
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.
Li JS; Tong SP; Wands JR
J Virol; 1996 Sep; 70(9):6029-35. PubMed ID: 8709225
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
5. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.
Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H
J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of DNA vaccines against duck hepatitis B virus infection.
Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ
J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203
[TBL] [Abstract][Full Text] [Related]
7. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.
Tong S; Li J; Wands JR
J Virol; 1995 Nov; 69(11):7106-12. PubMed ID: 7474130
[TBL] [Abstract][Full Text] [Related]
8. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
Borel C; Sunyach C; Hantz O; Trepo C; Kay A
Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
[TBL] [Abstract][Full Text] [Related]
10. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein.
Lambert V; Chassot S; Kay A; Trepo C; Cova L
Virology; 1991 Nov; 185(1):446-50. PubMed ID: 1718087
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of binding peptides on replication of duck hepatitis B virus].
Jia HY; Chen Z; Zhou LF; Chen F; Zhu HH; Liu JH; Xu XY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):116-20. PubMed ID: 15812883
[TBL] [Abstract][Full Text] [Related]
12. Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress.
Funk A; Hohenberg H; Mhamdi M; Will H; Sirma H
J Virol; 2004 Apr; 78(8):3977-83. PubMed ID: 15047813
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.
Zhang YY; Summers J
J Virol; 1999 May; 73(5):3616-22. PubMed ID: 10196253
[TBL] [Abstract][Full Text] [Related]
14. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
[TBL] [Abstract][Full Text] [Related]
15. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.
Li J; Tong S; Lee HB; Perdigoto AL; Spangenberg HC; Wands JR
J Virol; 2004 Feb; 78(4):1873-81. PubMed ID: 14747552
[TBL] [Abstract][Full Text] [Related]
16. Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.
Dallmeier K; Schultz U; Nassal M
PLoS Pathog; 2008 Dec; 4(12):e1000230. PubMed ID: 19057662
[TBL] [Abstract][Full Text] [Related]
17. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
19. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.
Yang W; Summers J
J Virol; 1998 Nov; 72(11):8710-7. PubMed ID: 9765413
[TBL] [Abstract][Full Text] [Related]
20. Duck hepatitis B virus replication in primary bile duct epithelial cells.
Lee JY; Culvenor JG; Angus P; Smallwood R; Nicoll A; Locarnini S
J Virol; 2001 Aug; 75(16):7651-61. PubMed ID: 11462037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
